TOP STORIES

• ORGANIZATION Single-Wholesaler Model Has No Merits for Hospitals: Hyogo Doctors Group
  September 7, 2023

• REGULATORY Japan Eyes AI-Driven Drug Discovery Project for Cancer, Intractable Diseases
  September 7, 2023

• BUSINESS Osaka Court Bars Sawai’s Teribone Generic over Manufacturing Patents
  September 6, 2023

• BUSINESS Santen to Run Voluntary Redundancy Program Targeting Age 50 and Up
  September 5, 2023

• REGULATORY Japan Approves Pfizer’s Omicron XBB.1.5 Vaccine, Moderna’s Still under Review
  September 4, 2023

• REGULATORY MHLW Must Streamline Operations via DX, Improve Staff’s Work-Life Balance: Official
  September 1, 2023

• REGULATORY Chuikyo Payer Rep Floats Deferred Price Cuts for PMP upon Generic Entries
  August 31, 2023

• BUSINESS Novartis Rolls Out Luxturna in Japan, 2 Treatment Facilities Selected
  August 31, 2023

• REGULATORY MHLW Top Pharma Officer Remains Committed to Fast, Safe Access to Good Drugs
  August 31, 2023

• REGULATORY Medical DX Office to Kick Off in September, Explore Better Use of Medical Data for Drug Discovery
  August 30, 2023

• BUSINESS First 10 Drugs Named for Medicare Price Negotiations, None from Japan Firms
  August 30, 2023

• ORGANIZATION JPMA on Alert for IRA’s Drug Pricing Provisions, Boosting Cooperation with PhRMA
  August 29, 2023

• REGULATORY Japan Panel Clears GSK’s Arexvy, 1st RSV Vaccine, for Approval
  August 29, 2023

• REGULATORY Japan to Shell Out Up to 30 Billion Yen for National Project to Spur Dementia R&D
  August 28, 2023

• REGULATORY MHLW Eyes Pediatric, Orphan Drug Advisory Team within PMDA: FY2024 Budget Request
  August 25, 2023

• ACADEMIA Ultra-High Cost of Luxturna Would Be Offset by Its Clinical Significance, Have Limited Financial Impact: Expert
  August 25, 2023

• REGULATORY Drug Pricing Organization Proposes Changes in PMP, Re-Pricing Criteria towards 2024 Reform
  August 24, 2023

• REGULATORY Chuikyo OKs Listing of Litfulo and More; 10 Billion-Plus Yen Peak Sales for Pfizer, Sobi Meds
  August 24, 2023

• REGULATORY Luxturna Priced at 49.6 Million Yen per Vial, Peak Sales Put at 500 Million Yen with 5 Patients
  August 24, 2023

• REGULATORY Hemlibra, Lynparza, Zejula Face Quarterly Re-Pricing, 7.7-10.2% Cut in November
  August 24, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 43
• 44
• 45
• 46
• 47
• 48
• 49
• 50
• 51
• …
• Next ›
• 最終 »